BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Esteban-Villarrubia J, Soto-Castillo JJ, Pozas J, San Román-Gil M, Orejana-Martín I, Torres-Jiménez J, Carrato A, Alonso-Gordoa T, Molina-Cerrillo J. Tyrosine Kinase Receptors in Oncology. Int J Mol Sci 2020;21:E8529. [PMID: 33198314 DOI: 10.3390/ijms21228529] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Xu W, Ye C, Qing X, Liu S, Lv X, Wang W, Dong X, Zhang Y. Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy. Mater Today Bio 2022;16:100358. [PMID: 35880099 DOI: 10.1016/j.mtbio.2022.100358] [Reference Citation Analysis]
2 Fujii J, Osaki T, Bo T. Ascorbate Is a Primary Antioxidant in Mammals. Molecules 2022;27:6187. [DOI: 10.3390/molecules27196187] [Reference Citation Analysis]
3 Wang X, Zhou Y, Wang Y, Wang X, Zhang Y, Mao Y, Zhang L, Qi J, Zhang Y, Lyu F, Gu L, Yu R, Zhou X. SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide. JCM 2022;11:4765. [DOI: 10.3390/jcm11164765] [Reference Citation Analysis]
4 Torres-jiménez J, Esteban-villarrubia J, Ferreiro-monteagudo R. Precision Medicine in Metastatic Colorectal Cancer: Targeting ERBB2 (HER-2) Oncogene. Cancers 2022;14:3718. [DOI: 10.3390/cancers14153718] [Reference Citation Analysis]
5 Fujii J, Homma T, Osaki T. Superoxide Radicals in the Execution of Cell Death. Antioxidants 2022;11:501. [DOI: 10.3390/antiox11030501] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
6 Grela-Wojewoda A, Pacholczak-Madej R, Adamczyk A, Korman M, Püsküllüoğlu M. Cardiotoxicity Induced by Protein Kinase Inhibitors in Patients with Cancer. Int J Mol Sci 2022;23:2815. [PMID: 35269958 DOI: 10.3390/ijms23052815] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Juan A, del Mar Noblejas-lópez M, Arenas-moreira M, Alonso-moreno C, Ocaña A. Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles. Front Cell Dev Biol 2022;9:805336. [DOI: 10.3389/fcell.2021.805336] [Reference Citation Analysis]
8 Carlin CR. Role of EGF Receptor Regulatory Networks in the Host Response to Viral Infections. Front Cell Infect Microbiol 2021;11:820355. [PMID: 35083168 DOI: 10.3389/fcimb.2021.820355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Yang K, Xu YC, Hu HY, Li YZ, Li Q, Luan YY, Liu Y, Sun YQ, Feng ZK, Yan YS, Yin CH. Investigation of a Novel NTRK1 Variation Causing Congenital Insensitivity to Pain With Anhidrosis. Front Genet 2021;12:763467. [PMID: 34938316 DOI: 10.3389/fgene.2021.763467] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Villamar-Cruz O, Loza-Mejía MA, Arias-Romero LE, Camacho-Arroyo I. Recent advances in PTP1B signaling in metabolism and cancer. Biosci Rep 2021;41:BSR20211994. [PMID: 34726241 DOI: 10.1042/BSR20211994] [Reference Citation Analysis]
11 Ratajczak M, Gaweł D, Godlewska M. Novel Inhibitor-Based Therapies for Thyroid Cancer-An Update. Int J Mol Sci 2021;22:11829. [PMID: 34769260 DOI: 10.3390/ijms222111829] [Reference Citation Analysis]
12 Jackson CW, Pratt CM, Rupprecht CP, Pattanaik D, Krishnaswamy G. Mastocytosis and Mast Cell Activation Disorders: Clearing the Air. Int J Mol Sci 2021;22:11270. [PMID: 34681933 DOI: 10.3390/ijms222011270] [Reference Citation Analysis]
13 Kikuya M, Furuichi K, Hirao T, Endo S, Toyooka N, Ito K, Aoki S. Aldo-keto reductase inhibitors increase the anticancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia. J Pharmacol Sci 2021;147:1-8. [PMID: 34294359 DOI: 10.1016/j.jphs.2021.05.001] [Reference Citation Analysis]
14 Ferrari E, Naponelli V, Bettuzzi S. Lemur Tyrosine Kinases and Prostate Cancer: A Literature Review. Int J Mol Sci 2021;22:5453. [PMID: 34064250 DOI: 10.3390/ijms22115453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Schaller E, Ma A, Gosch LC, Klefenz A, Schaller D, Goehringer N, Kaps L, Schuppan D, Volkamer A, Schobert R, Biersack B, Nitzsche B, Höpfner M. New 3-Aryl-2-(2-thienyl)acrylonitriles with High Activity Against Hepatoma Cells. Int J Mol Sci 2021;22:2243. [PMID: 33668139 DOI: 10.3390/ijms22052243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]